These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

195 related items for PubMed ID: 2645702

  • 1. Renal allograft biopsy and conversion of cyclosporine to azathioprine.
    Shen SY, Weir MR, Coughlin TR.
    Transplantation; 1989 Feb; 47(2):223-9. PubMed ID: 2645702
    [Abstract] [Full Text] [Related]

  • 2. Amelioration of chronic renal allograft dysfunction in cyclosporine-treated patients by addition of azathioprine.
    Rocher LL, Hodgson RJ, Merion RM, Swartz RD, Keavey S, Turcotte JG, Campbell DA.
    Transplantation; 1989 Feb; 47(2):249-54. PubMed ID: 2645707
    [Abstract] [Full Text] [Related]

  • 3. Results of the Minnesota randomized prospective trial of cyclosporine versus azathioprine-antilymphocyte globulin for immunosuppression in renal allograft recipients.
    Sutherland DE, Fryd DS, Strand MH, Canafax DM, Ascher NL, Payne WD, Simmons RL, Najarian JS.
    Am J Kidney Dis; 1985 Jun; 5(6):318-27. PubMed ID: 3893106
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Results of conversion from cyclosporine to azathioprine in cadaveric renal transplantation.
    Gonwa TA, Nghiem DD, Schulak JA, Corry RJ.
    Transplantation; 1987 Feb; 43(2):225-8. PubMed ID: 3544380
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Correlation of clinical outcomes after tacrolimus conversion for resistant kidney rejection or cyclosporine toxicity with pathologic staging by the Banff criteria.
    Morrissey PE, Gohh R, Shaffer D, Crosson A, Madras PN, Sahyoun AI, Monaco AP.
    Transplantation; 1997 Mar 27; 63(6):845-8. PubMed ID: 9089224
    [Abstract] [Full Text] [Related]

  • 8. Elective conversion from cyclosporine to azathioprine in recipients with stable renal function 6 months after kidney transplantation.
    Thistlethwaite JR, Haag BW, Jones KW, Stuart JK, Stuart FP.
    Hum Immunol; 1985 Nov 27; 14(3):314-23. PubMed ID: 3902749
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Sequential use of Minnesota antilymphoblast globulin and cyclosporine in cadaveric renal transplantation.
    Kupin WL, Venkatachalam KK, Oh HK, Dienst S, Levin NW.
    Transplantation; 1985 Dec 27; 40(6):601-4. PubMed ID: 3907029
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group.
    Gruessner RW.
    Clin Transplant; 1997 Aug 27; 11(4):299-312. PubMed ID: 9267719
    [Abstract] [Full Text] [Related]

  • 14. Aggressive needle biopsy protocol prevents loss of renal allografts to undetected rejection during early posttransplant dysfunction.
    Thistlethwaite JR, Woodle ES, Mayes JT, Stuart JK, Heffron TG, Spargo BH, Stuart FP.
    Transplant Proc; 1989 Feb 27; 21(1 Pt 2):1890-2. PubMed ID: 2652614
    [No Abstract] [Full Text] [Related]

  • 15. A prospective randomised comparative study on the influence of cyclosporin and azathioprine on renal allograft survival and function.
    Henny FC, Kootte AM, Van Bockel JH, Baldwin WM, Hermans J, Bos B, van Es LA, Paul LC.
    Nephrol Dial Transplant; 1986 Feb 27; 1(1):44-9. PubMed ID: 3110662
    [Abstract] [Full Text] [Related]

  • 16. HLA-identical renal transplants: impact of cyclosporine on intermediate-term survival and renal function.
    Sumrani N, Delaney V, Ding ZK, Butt K, Hong J.
    Am J Kidney Dis; 1990 Nov 27; 16(5):417-22. PubMed ID: 2239931
    [Abstract] [Full Text] [Related]

  • 17. Improved outcome of renal transplantation with cyclosporine compared with azathioprine--experience in 33 recipients followed for over one year.
    Yasumura T, Ohmori Y, Aikawa I, Fukuda M, Suzuki S, Nakai I, Matsui S, Oka T.
    Jpn J Surg; 1986 May 27; 16(3):181-8. PubMed ID: 3525928
    [Abstract] [Full Text] [Related]

  • 18. Effect of early cyclosporine levels on kidney allograft rejection.
    Johnson EM, Canafax DM, Gillingham KJ, Humar A, Pandian K, Kerr SR, Najarian JS, Matas AJ.
    Clin Transplant; 1997 Dec 27; 11(6):552-7. PubMed ID: 9408683
    [Abstract] [Full Text] [Related]

  • 19. Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients. U.S. Renal Transplant Mycophenolate Mofetil Study Group.
    Sollinger HW.
    Transplantation; 1995 Aug 15; 60(3):225-32. PubMed ID: 7645033
    [Abstract] [Full Text] [Related]

  • 20. An increased incidence of late acute rejection episodes in cadaver renal allograft recipients given azathioprine, cyclosporine, and prednisone.
    Wrenshall LE, Matas AJ, Canafax DM, Min DI, Sibley RJ, Dunn DL, Payne WD, Sutherland DE, Najarian JS.
    Transplantation; 1990 Aug 15; 50(2):233-7. PubMed ID: 2382291
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.